Clinical Trials Browser

Suspended × Breast Neoplasms × Interleukin-2 × Clear all

NCT00673829 2016-06-17

Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer

Phase 1 Suspended

Breast Neoplasms